Switching to another prostaglandin analogue that does not contain benzalkonium chloride may not be the answer for managing patients complaining of dryness and irritation while using latanoprost 0.005%, according to the results of a prospective, double-masked, randomized clinical study by eye-care professionals at Lackland Air Force Base.
Pooled results from two randomized, investigator-masked parallel group clinical trials show that the fixed combination of 0.2% brimonidine-0.5% timolol produced greater IOP lowering than the fixed combination of 0.2% dorzolamide-0.5% timolol, whether the fixed combination products were used alone or as an adjunct to existing treatment with a prostaglandin analogue.
Timolol maleate 0.5%/sorbitol complex is a convenient, effective and well-tolerated choice for adjunctive therapy in patients on a prostaglandin analogue who need further intraocular pressure control, according to a clinical trial.
Ongoing development of dry eye treatments in the pipeline aims to address the range of etiologies and pathophysiologies present across patients with dry eye syndrome.
There are a number of therapeutic options for mitigating ocular pain, but proper diagnosis of the underlying cause is the first principle in appropriate pain management.
During tough economy, some try to economize by cutting back on medication use.
When patients visit Greg E. Evans, OD, at his practice near Palm Springs, CA, a routine part of the exam includes a thorough assessment of their macular health.
Advances in pharmacotherapy, including intravitreal administration of corticosteroids and inhibitors of vascular endothelial growth factor, have improved management of retinal vein occlusions.